DEsmond

    • DEsmondDEsmond
      ·04-10
      Share your opinion about this news…

      Singapore Shares Close Shy of 5,000 Milestone as Islamabad Peace Talks Boost Sentiment

      Singapore shares recorded gains on Friday to end the week in green, as the Asian market reacted positively to a tentative geopolitical de-escalation in the Middle East ahead of the highly anticipated talks between the US and Iran in Islamabad.The Straits Times Index , a key benchmark for the Singapore Exchange, ranged between 4,973.10 and 4,999.30 throughout the day. It ended the session at 4,989.41, up 12.33 points or nearly 0.3% compared to Thursday's close.On the corporate front, shares of BH Global were down nearly 7% at the close as it proposed to renew its share buyback mandate.Metis Energy closed over 2% higher as it reported three consecutive years of pre-tax losses for its three most recent financial years.Meanwhile, shares of City Developments were nearly flat as it established a SG$2 billion multicurrency perpetual bonds issuance program.
      Singapore Shares Close Shy of 5,000 Milestone as Islamabad Peace Talks Boost Sentiment
      252Comment
      Report
    • DEsmondDEsmond
      ·2024-05-20
      Share your opinion about this news…

      AstraZeneca Plans to Build $1.5 Bln Manufacturing Facility in Singapore

      May 20 - AstraZeneca said on Monday it plans to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates portfolio.The greenfield facility, which will be the drugmaker's first end-to-end ADC production site, will be supported by Singapore Economic Development.ADCs are engineered antibodies that bind to tumour cells and then release cell-killing chemicals."Singapore is one of the world's most attractive countries for investment given its repu
      AstraZeneca Plans to Build $1.5 Bln Manufacturing Facility in Singapore
      712Comment
      Report
    • DEsmondDEsmond
      ·2023-06-15
    • DEsmondDEsmond
      ·2023-06-12
       
       
       
       

      Most Discussed